Search

Search Constraints

You searched for: Author/Creator Morse, Michael A.

Search Results

1. A phase I study of ABT‐510 plus bevacizumab in advanced solid tumors. (21st March 2013)

2. A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. (23rd March 2018)

3. A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas. (13th March 2013)

4. A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma. Issue 1 (20th September 2016)

5. Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy. (3rd April 2017)

8. Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy. (1st January 2021)

9. Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer. (9th February 2021)

10. Cabozantinib and Panitumumab for RAS Wild‐Type Metastatic Colorectal Cancer. (9th February 2021)